Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species modulator 1 (ROMO1) is a nuclear-encoded mitochondrial inner membrane protein with dual functions as a modulator of reactive oxygen species (ROS) production and as a viroporin-like non-selective ion channel. ROMO1 consists of 79 amino acids, integrates into the inner mitochondrial membrane, and forms homo-oligomeric channels involved in ion homeostasis. It plays a key role in mitochondrial dynamics, facilitating mitochondrial fusion and cristae formation. ROMO1-derived ROS are essential for cell cycle progression, cellular proliferation, and normal redox signaling, but excess activity leads to cellular stress, apoptosis, and is associated with various disease states including cancer, where it may contribute to tumor progression, recurrence, and therapy resistance. ROMO1 is evolutionarily conserved and serves as a potential therapeutic target and biomarker for cancer and other oxidative stress–related diseases.
Inhibition of non-selective cation channel activity (e.g., by HMA); Modulation of ROS-dependent signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species modulator 1 (ROMO1).